Campaigning News
Brain tumours kill more children and adults under the age of 40 than any other cancer
Isabella’s diagnosis was “death sentence”

A
mum who donated her five-year-old daughter’s brain for research after she died
from a brain tumour is calling for support of our new petition.
Isabella
Ortiz was diagnosed with a diffuse
intrinsic pontine glioma (DIPG) in
June 2017. She had chemotherapy but when she ran out of treatment options on
the NHS, her parents crowdfunded £120,000 to pay for a private trial at The
Harley Street Clinic in London.
Isabella’s
mum Assunta said: “We quickly learned what a DIPG diagnosis really meant. It
was a death sentence. It wasn’t if Isabella would die, but when.”
The
clinical trial extended Isabella’s life, but sadly she died on 19th
October 2019.
Assunta
is now supporting our petition calling on the Government to ring-fence £110 million of
current and new funding to kick-start an increase in the national investment in
brain tumour research to £35 million a year by 2028.
She
added: “Money is so important because, without it, there is no research. The
Government needs to invest much more into studying DIPGs because so much is
still unknown about them. We donated Isabella’s tissue for research but it took
several months for that to happen, so I want to see a more effective procedure
for parents to be able to donate their children’s tissue for research. Only
then can the researchers test it to see how DIPG mutates so they can then
develop drugs that counteract that. The donation process needs to be quicker
and easier so other children don’t die for nothing.”
We
need your support to reach our goal of 100,000 signatures in the hope of
prompting a parliamentary debate. Every signature counts – please sign here.
Once
you have signed, please share the petition with your networks as widely as you
can – via social media, email, text message and WhatsApp – and help spread the
word.
Related
reading:
If you found this story interesting or helpful, sign up to our weekly e-news and keep up to date with all the latest from Brain Tumour Research.